Categories Uncategorized

Tips on Meeting FDA Device Design Requirements

Are you a device manufacturer in the medical industry? Then you may be thinking that the FDA design controls are confusing terms on your process. These regulatory design requirements shouldn’t be shrouded in confusion, and we share some tips below that will help you enjoy being a biomedical product designer who meets or even surpasses the FDA regulatory requirements.

It Would Be Best If You Didn’t Believe in Misconceptions

A heavy load of documentation has been the biggest misconception about meeting the FDA design controls. If you have volumes of documentation on how to meet FDA design requirements, then your design controls are obsolete, and they need a complete overhaul. Design controls should not be a burden to medical device developers since there are other, more straightforward ways of complying. Meeting design controls entails demonstrating the safety, effectiveness, and the intended use of the product. Make a product that meets this criteria, and you more likely than not will meet the FDA requirements.

Keep Your Plan Fluid

A huge mistake that is always seen is that companies treat design control as a task to get out of their way. In most cases, it is always done at the beginning of the project, then forgotten. An effective plan should have the beginning, middle, then the final phase. Your design and development plan needs to be dynamic and address FDA controls at every step. It should be developed and updated in every phase of development and should be flexible for change. A fluid plan will identify the process that you will follow, the design to be used, and the required materials.

Recognize User Needs vs. Design Inputs

The difference between design inputs and user needs in an important concept that you need to be aware of. Your question should be what will the user use this device for? And how will they interact with the product? The responses to these questions are what you need to indicate in the user needs. A simple way to satisfy the user needs is by using standard terms such as “easy to use,” “better,” and so on.

User stories should become the basis of your design inputs as these will make the user stories measurable and more specific. The inputs are simply the requirements for the design of your device. Furthermore, the inputs need to be objective and stated in a way that they can be demonstrated through analysis and testing.

Recognizing Design Inputs vs. Design Outputs vs. Design Verification

Design inputs will define all the requirements, performance criteria, and features of your medical device product. Device inputs should come directly from the user’s needs since a useful design input gives a stronger foundation for a successful medical device.

Design outputs consist of all components, inspection procedures, parts, and other materials that go into your medical device. They also include all documentation to be given to someone who needs to assemble the device.

Design verification has the role of proving that design outputs meet design inputs. It also includes analyzing, testing and inspecting, which served as proof that your medical device was designed well.

All these factors work collectively to make adhering to all FDA design controls easy. Established players in the biomedical space, such as Vivos Therapeutics Inc. certainly know the design controls like their back of their hand, and newcomers in the field would do well to learn from these pros.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

The 47% Signal: Why Earth Science Tech Inc.’s (ETST) Management Is Betting the House on ETST

While many capitalization structures are diluted in the landscape of over-the-counter (“OTC”) markets, Earth Science…

1 hour ago

The US Formally Exits the World Health Organization

The United States has formally communicated its immediate withdrawal from the World Health Organization (WHO), denying…

2 days ago

Meta Analysis Finds That Weight Reduction Reduces Severity of Psoriasis

Psoriasis is a chronic skin condition that afflicts at least 60 million individuals globally. Nearly 80% of these affected people also…

6 days ago

New Digital Twin Predicts Outcomes of Brain Cancer Treatments

Researchers at the University of Michigan (U-M) have developed a system that leverages both AI…

1 week ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy

LIXTE is developing a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments…

1 week ago

Scientists Develop Next-Gen Antibodies That Boost the Body’s Cancer Killing Cells

Scientists at Southampton University have created new antibodies that supercharge the immune system’s ability to identify and kill cancer…

1 week ago